aim
review
therefor
elucid
mechan
ali
pathogenesi
focus
two
main
theori
first
neutrophil
pmn
play
central
role
drive
ali
second
lung
epitheli
cell
apoptosi
repres
import
patholog
aspect
induc
lung
injuri
regard
discuss
data
field
well
find
use
clinic
relev
doublehit
mous
model
indirect
ali
induc
hemorrhag
shock
subsequ
polymicrobi
sepsi
addit
novel
strategi
ie
use
sirna
mous
lung
vivo
serv
us
broaden
understand
patholog
ali
pathophysiolog
mechan
ali
insuffici
understood
common
final
heterogen
entiti
alveolocapillari
barrier
compromis
allow
consecut
edema
format
interstitium
well
alveoli
thu
compromis
ga
exchang
lead
organ
dysfunct
respiratori
failur
histolog
evalu
lung
ali
patient
indic
substanti
accumul
activ
pmn
diffus
alveolar
damag
loss
epitheli
integr
increas
pulmonari
edema
sever
propos
mechan
believ
account
phenomenon
among
leukocyt
pmn
consid
first
line
defens
microorgan
rapidli
recruit
inflammatori
siteorgan
exert
varieti
primarili
benefici
function
phagocytosi
product
reactiv
oxygen
speci
ro
nitric
oxid
speci
no
degranul
lytic
enzym
etc
well
orchestr
enabl
clearanc
invad
pathogen
howev
also
hypothes
activ
pmn
may
possess
harm
potenti
function
direct
otherwis
normal
host
tissu
culmin
injuri
organ
damag
figur
sub
figur
propos
mechan
acut
lung
injuri
hemorrhag
shock
hem
prime
inflamm
inflr
color
apoptosi
ao
gray
color
injuri
trigger
subsequ
infecti
insult
rest
lung
prime
diverg
inflammatori
mediat
releas
initi
event
exampl
shock
inflamm
etc
act
number
cell
blood
monocyt
pmn
neutrophil
lung
ep
epitheli
cell
ec
endotheli
cell
alveolar
macrophag
b
cell
turn
stimul
either
separ
concomitantli
proinflammatori
respons
andor
ao
small
number
ep
fasfasl
activ
releas
chemokin
like
prime
later
time
subsequ
inflammatoryinfecti
trigger
event
take
place
c
local
ec
andor
ep
becom
activ
releas
chemokin
activ
agent
recruit
prime
activ
leukocyt
pmn
lung
activ
leukocyt
transmigr
interstitium
alveoli
perform
effector
role
absenc
infect
effector
respons
may
sole
injuri
addit
may
propel
inflammatoryapoptot
respons
viciou
cycl
activ
fa
fasl
cell
surfac
e
stantial
evid
lung
particularli
suscept
pmn
accumul
contrast
organ
pmn
sequestr
occur
postcapillari
venul
pulmonari
pmn
retent
take
place
within
pulmonari
capillari
repres
complex
interconnect
network
short
capillari
segment
cours
arteriol
venul
cross
numer
alveolar
wall
often
includ
capillari
segment
blood
complex
network
contain
time
pmn
compar
vascular
bed
review
pmn
accumul
observ
earli
lung
tissu
well
bronchoalveolar
lavag
fluid
balf
ard
patient
develop
neutropenia
ali
rapidli
progress
pmn
count
restor
furthermor
degre
neutrophilia
balf
correl
poor
prognosi
septic
ard
experiment
set
indirect
ali
stem
hemorrhag
shock
hem
follow
polymicrobi
sepsi
found
respons
hem
circul
pmn
exhibit
ex
vivo
increas
respiratori
burst
capac
decreas
apoptosi
consist
concept
shockinjuri
produc
vivo
prime
signific
could
seen
hem
follow
sepsi
recruit
pmn
lung
occur
along
develop
ali
also
hemprim
pmn
inject
intraven
pmndeplet
anim
subsequ
underw
cecal
ligat
punctur
clp
induc
sepsi
ali
result
upon
background
use
differ
model
ali
other
found
deplet
pmn
actual
may
serv
decreas
injuri
associ
ali
thu
deplet
pmn
prior
hem
sepsi
markedli
reduc
extent
lung
inflamm
amelior
lung
protein
influx
sever
ali
line
find
transfusioninduc
ali
inflamm
close
link
pathogenesi
ali
level
interleukin
il
found
increas
lung
ali
patient
persist
increas
inflammatori
cytokin
lung
correl
poor
outcom
ali
inflammatori
mediat
exert
sever
effect
pmn
exampl
complement
protein
activ
pmn
thu
contribut
pulmonari
sequestr
mediat
lung
tissu
injuri
sever
inflammatori
mediat
includ
complement
cytokin
chemokin
lipid
mediat
also
abl
induc
express
surfac
molecul
endothelium
promot
pmn
recruit
tumor
necrosi
factor
tnf
two
import
cytokin
found
regularli
balf
ard
patient
higher
concentr
plasma
thu
support
local
origin
howev
antitnf
therapi
fail
protect
septic
patient
ali
proinflammatori
cytokin
also
regularli
express
activ
pmn
travel
lung
appear
relev
sourc
favor
subsequ
releas
mediat
howev
earli
antiinflammatori
respons
driven
tnfand
earli
peak
level
also
shown
ard
patient
addit
pmn
stimul
lipopolysaccharid
lp
show
activ
nuclear
factor
kappa
b
akt
degre
nuclear
transloc
peripher
pmn
patient
septic
ali
link
ventil
time
surviv
pmn
way
lungsequestr
adhes
migrat
activ
tissu
injuri
first
respons
inflammatori
mediat
pmn
migrat
pulmonari
capillari
prepar
extravas
figur
initi
chang
cytoskeleton
prevent
pmn
deform
make
less
like
pass
pulmonari
capillari
regard
activ
pmn
ard
patient
appear
even
rigid
septic
patient
second
emigr
pmn
passag
endothelium
regul
adhes
molecul
initi
sequestr
appear
independ
adhes
molecul
durabl
process
could
reli
thu
lselectindefici
mice
show
normal
pool
margin
pmn
cleavag
lselectin
pmn
surfac
alter
margin
lselectin
defici
mice
exhibit
short
transient
leukopenia
respons
complement
activ
pmn
adher
endotheli
cell
use
interact
intercellular
adhes
endotheli
side
thu
pmn
emigr
respons
escherichia
coli
ecoli
ecoli
lipopolysaccharid
pseudomona
aeruginosa
immunoglobulin
ig
g
immun
complex
mediat
appear
case
respons
streptococcu
pneumonia
group
b
streptococcu
staphylococcu
aureu
hyperoxia
even
migrat
block
reduc
pmn
emigr
suggest
redund
mechan
mediat
effect
cytokin
chemokin
also
shown
involv
increas
avid
import
understand
activ
pmn
associ
close
endotheli
interact
mediat
adhes
molecul
roll
pmn
might
well
integr
sum
total
input
receiv
scan
endothelium
activ
threshold
reach
switch
highaffin
conform
redistribut
cell
surfac
trigger
arrest
adhes
howev
integrin
also
involv
pmn
migrat
phagocytosi
respiratori
burst
even
cytokin
product
elud
chemokin
critic
involv
activ
recruit
pmn
lung
potenti
contribut
harm
effect
organ
level
regard
associ
chemokin
lung
neutrophil
influx
alveolocapillari
dysfunct
report
experi
observ
hemorrhageinduc
septic
ali
well
experiment
blunt
chest
trauma
chemokin
markedli
upregul
local
lung
anim
well
system
blockad
cxcr
chemokin
cxc
motif
receptor
use
antileukin
hexapeptid
inhibitor
follow
hem
reduc
lung
pmn
influx
respons
subsequ
sepsi
addit
decreas
lung
inflamm
lung
protein
leak
pulmonari
level
markedli
increas
also
administ
antikc
antibodi
mice
immedi
follow
hem
adopt
transfer
pmn
isol
antimip
antikctr
donor
exhibit
reduct
lung
inflamm
lung
pmn
influx
recipi
respons
sepsi
compar
control
igtreat
donor
data
demonstr
hemorrhageinduc
prime
pmn
mediat
experiment
ali
also
process
differenti
effect
kc
although
signal
mice
howev
human
util
place
two
mous
receptor
ie
also
util
differ
murin
chemokin
data
may
translat
directli
patient
set
aliard
activ
pmn
reach
lung
possess
potenti
induc
tissu
injuri
releas
rosno
long
thought
central
effector
mechan
pmnmediat
lung
injuri
regard
inhibit
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
attenu
sepsisassoci
ali
surprisingli
nadph
oxidasedefici
anim
protect
complementinduc
ali
hand
inhibit
defici
nitric
oxid
synthetas
show
protect
complement
endotoxininduc
ali
howev
ro
no
also
play
addit
role
signal
molecul
modul
kinas
phosphatas
receptor
transcript
factor
review
complic
interpret
whether
net
pulmonari
effect
one
harm
help
proteolyt
enzym
also
part
pmn
pathogenclear
arsen
neutrophil
elastas
cathepsin
g
metalloproteinas
import
role
clear
invad
pathogen
function
aspect
tissu
remodelingwound
heal
also
abl
mediat
neutrophilinduc
tissu
damag
degrad
extracellular
matrix
effici
thu
inhibit
neutrophil
elastas
improv
respiratori
function
septic
ali
defici
also
render
mice
suscept
gram
neg
gram
posit
sepsi
addit
defici
elastas
andor
cathepsin
g
accompani
increas
suscept
fungal
infect
decreas
suscept
endotoxinmedi
inflammatori
ali
activ
gelatinas
correl
protein
accumul
epitheli
line
fluid
ard
patient
might
therefor
potenti
marker
ard
inhibit
matrix
metalloproteinas
elastas
prevent
lung
dysfunct
reduc
septic
ali
pig
detail
mechan
pmn
mediat
ali
via
involv
proteolyt
enzym
review
detail
elsewher
regul
pmn
apoptosi
neutrophil
matur
exhibit
constitut
form
program
cell
death
life
span
h
circul
normal
circumst
activ
pmn
elimin
fairli
quickli
invad
pathogen
clear
sever
inflammatori
agent
lp
tnf
granulocyt
macrophag
colonystimul
factor
g
csf
etc
inhibit
pmn
apoptosi
delay
apoptot
respons
provid
pmn
longer
life
span
turn
allow
accumul
local
tissu
site
inflammationinfect
respect
pmn
obtain
patient
follow
major
trauma
burn
injuri
sepsi
ard
show
evid
decreas
apoptosi
antiapoptot
effect
ard
plasma
pmn
appear
mediat
gmcsf
receptor
sepsi
delay
apoptosi
associ
decreas
activ
prolong
mainten
mitochondri
membran
potenti
delay
pmn
apoptosi
also
involv
activ
regul
cxc
receptor
pmn
howev
controversi
persist
whether
sustain
activ
actual
contribut
organ
injuri
activ
pmn
shown
exert
damag
effect
lung
howev
follow
gcsf
treatment
pneumonia
patient
differ
outcom
time
recoveri
note
appear
complic
ard
decreas
data
complement
studi
indic
gmcsf
air
space
associ
improv
surviv
patient
ard
model
hemorrhageinduc
septic
ali
evid
prolong
lifespan
activ
pmn
use
transgen
mice
overexpress
antiapoptot
protein
myeloidrestrict
fashion
exacerb
acut
lung
injuri
although
prolong
presenc
activ
pmn
lung
evid
contrast
observ
initi
surviv
benefit
life
span
pmn
prolong
like
due
enhanc
capac
clear
bacteria
evidenc
lower
bacteria
count
lung
addit
inflammatori
noninfecti
environ
sir
mimick
intraperiton
inject
e
colilp
prolong
lifespan
activ
pmn
detriment
anim
surviv
associ
exacerb
lung
injuri
addit
noninfecti
inflammatori
ali
failur
clear
pmn
lung
contribut
increas
inflamm
mortal
togeth
data
impli
tissu
environ
infecti
versu
inflammatori
neutrophil
encount
play
import
role
determin
whether
pmn
mediat
organ
damag
howev
mechan
determin
whether
pmn
turn
bad
good
understood
well
requir
investig
inform
make
strong
case
pmn
play
signific
role
ali
howev
interest
note
ard
describ
develop
patient
neutropenia
addit
follow
gcsf
therapi
pneumonia
sepsi
patient
incid
ard
increas
experiment
ali
pneumonia
pmn
shown
migrat
lung
without
exert
deleteri
effect
thu
mechan
also
like
involv
pathogenesi
ali
develop
aliard
loss
epitheli
cell
lung
consecut
impair
integr
alveolocapillari
barrier
commonli
note
type
epitheli
cell
make
approxim
pulmonari
surfac
type
ii
epitheli
cell
account
critic
produc
surfact
may
differenti
type
cell
impair
alveolar
epitheli
barrier
mani
way
import
develop
ali
one
hand
epitheli
barrier
physiolog
condit
less
permeabl
compar
endotheli
barrier
thu
destruct
integr
prompt
progress
influx
proteinrich
fluid
alveoli
hand
loss
epitheli
integr
repres
impair
physiolog
transepitheli
fluid
transport
inhibit
reabsorpt
alveolar
edema
thu
isol
injuri
endothelium
still
leav
intact
capac
epithelium
counteract
pulmonari
edema
format
fluid
balanc
becom
rapidli
disturb
upon
injuri
lung
epithelium
therefor
surpris
extent
epitheli
damag
impair
edema
reabsorpt
link
clinic
outcom
ali
addit
accompani
reduct
surfact
product
led
via
increas
surfac
tension
augment
respiratori
effort
affect
ga
exchang
program
cell
deathapoptosi
lung
epitheli
cell
repres
potenti
import
mechan
contribut
loss
cell
type
develop
ali
figur
bachhofen
et
al
report
patient
die
ard
exhibit
excess
apoptot
alter
chromatin
alveolar
type
ii
cell
subsequ
studi
confirm
dna
fragment
well
increas
express
proapoptot
protein
bax
associ
x
protein
recent
studi
also
suggest
role
lung
epitheli
cell
apoptosi
pediatr
ard
importantli
epitheli
cell
pmn
apoptosi
differenti
regul
ard
mention
earlier
pmn
show
decreas
rate
apoptosi
increas
markedli
epitheli
cell
local
mediat
lung
patient
may
regul
oppos
effect
interestingli
induct
lung
epitheli
cell
apoptosi
appear
lead
develop
ali
aggrav
apoptosi
addit
induc
macrophag
furthermor
inhibit
apoptosi
use
caspas
inhibitor
protect
mice
lethal
consequ
endotoxinassoci
ali
addit
bclx
l
treatment
reduc
albumin
leakag
lung
tissu
damag
lpsmediat
ali
induct
lung
apoptosi
ali
fa
apoptot
death
receptor
pathway
mediat
cell
death
also
appear
play
major
role
figur
regard
endotoxininduc
ali
increas
fa
express
epitheli
cell
well
immigr
fasligand
fasl
express
cell
lung
observ
human
lung
epitheli
cell
also
express
fa
particularli
distal
airway
sensit
fasmedi
apoptosi
caspasecleav
marker
epitheli
cell
apoptosi
also
increas
balf
ard
ali
ard
increas
concentr
fa
fasl
patient
balf
lung
tissu
detect
balf
ard
patient
shown
induc
apoptosi
healthi
lung
epitheli
cell
furthermor
ard
nonsurvivor
exhibit
markedli
higher
fasl
concentr
compar
survivor
particularli
septic
ali
infectionsever
depend
activ
fasfasl
system
lung
observ
fasl
concentr
report
much
higher
local
system
suggest
origin
pulmonari
respect
appear
sever
potenti
sourc
fasl
infiltr
monocyt
implic
alveolar
macrophag
pmn
implic
fasl
may
cleav
cell
membran
activ
matrix
metalloproteinas
howev
antiapoptot
protein
solubl
fa
also
appear
increas
ard
describ
correl
clinic
featur
pao
fio
ratio
may
point
toward
simultan
activ
protect
antiapoptot
mechan
ali
experiment
condit
instil
fasactiv
antibodi
murin
lung
induc
apoptosi
lung
epitheli
cell
pmn
recruit
impair
alveolocapillari
barrier
develop
fasdepend
lung
injuri
link
fasexpress
nonmyeloid
myeloid
cell
furthermor
block
fasfasl
system
reduc
develop
endotoxinmedi
ali
experi
demonstr
relev
fasmedi
apoptosi
lung
heminduc
septic
ali
fa
fasl
mutant
anim
exhibit
less
pulmonari
epitheli
cell
apoptosi
respons
insult
compar
background
anim
addit
extent
ali
assess
histolog
protein
influx
diminish
significantli
associ
surviv
benefit
fa
mutant
mice
compar
background
anim
also
report
fasfasl
defici
associ
reduct
degre
injuri
seen
direct
ali
e
coli
aureu
pneumonia
sepsi
model
similar
result
describ
sepsi
induc
legionella
pneumonia
contrast
data
pulmonari
sepsi
follow
lung
infect
p
aeruginosa
suggest
reduct
lung
apoptosi
absenc
fa
signal
well
decreas
surviv
rate
observ
associ
increas
dissemin
bacteria
note
fasmedi
apoptosi
lung
appear
modul
sever
factor
surfact
protein
angiotensin
ii
transform
growth
factor
tgf
beta
decoy
receptor
etc
review
apoptot
pathway
exampl
mediat
mitochondria
appear
play
role
certain
circumst
recent
studi
suggest
activ
fa
serv
induc
apoptosi
also
induc
secret
cytokin
chemokin
varieti
cell
type
figur
murin
lung
activ
fa
initi
profound
inflammatori
respons
earli
gener
chemokin
subsequ
recruit
neutrophil
respons
could
reduc
antagon
fa
ligand
trigger
fa
also
led
increas
concentr
monocyt
chemotact
protein
mcp
compromis
alveolocapillari
barrier
lpsmediat
pulmonari
inflamm
also
appear
regul
fa
mice
genet
alter
express
fa
either
myeloid
nonmyeloid
cell
lung
present
mark
increas
inflammatori
mediat
follow
fa
activ
contrast
non
alter
mice
lung
respect
cell
type
involv
indic
activ
fa
monocyt
cell
line
induc
product
activ
inflammatori
program
fa
also
shown
periton
macrophag
monocyt
macrophag
endotheli
cell
other
experi
fa
fasl
mutant
mice
show
mark
decreas
inflamm
lung
anim
respons
hemorrhageinduc
septic
ali
compar
background
anim
phenomenon
also
evid
follow
fa
silenc
mous
lung
use
sirna
associ
case
reduct
pmn
immigr
lung
experi
reveal
lung
epitheli
cell
capabl
secret
kc
vitro
respons
fa
activ
mechan
involv
erk
potenti
flip
complement
find
research
demonstr
depend
mechan
appear
underli
respons
instil
fasactiv
antibodi
transgen
murin
lung
lung
macrophag
number
markedli
reduc
display
similar
inflammatori
respons
seen
background
anim
support
role
fasmedi
ep
itheli
cellinduc
pulmonari
inflamm
vivo
fact
inhibit
fa
activ
modul
pmn
recruit
lung
well
pulmonari
epitheli
apoptosi
intriguingli
point
valu
potenti
therapeut
target
ali
use
silenc
rna
sirna
repres
potenti
power
experiment
approach
allow
us
better
understand
evolv
patholog
ali
may
possibl
repres
novel
therapeut
approach
treatment
condit
histori
sirna
discoveri
develop
mechan
involv
well
success
initi
use
mammal
vivo
describ
elsewher
respect
applic
vivo
lung
appear
good
candid
access
straightforwardli
intranas
intratrach
nevertheless
nucleic
acid
transfer
effici
diminish
substanti
phospholipid
protein
major
compon
airway
surfac
liquid
interestingli
unlik
system
deliveri
nake
sirna
lung
proven
effici
thu
potenti
complex
costli
approach
use
vector
system
chemic
sirna
modif
may
necessari
regard
deliveri
sirna
inhibitor
sar
coronaviru
glucos
superior
even
reduc
sever
diseas
given
modifi
calf
pulmonari
surfac
activ
materi
earli
feasibl
surfactantbas
nake
sirna
approach
mous
lung
target
dehydrogenas
gapdh
heme
ischemiareperfus
respect
demonstr
phase
iii
trial
respiratori
syncyti
viru
conduct
way
evalu
safeti
toler
antivir
activ
sirna
treatment
human
lung
respect
applic
sirna
vivo
set
lung
initi
attempt
extend
observ
blockad
kc
convent
antibodi
effect
develop
ali
use
vivo
approach
silenc
chemokin
local
lung
subsequ
initi
studi
antiapoptot
sirna
fa
assess
capac
protect
lung
detriment
effect
hemorrhageinduc
septic
ali
howev
establish
initi
feasibl
vivo
sirna
administr
mice
overexpress
green
fluoresc
protein
gfp
chosen
receiv
singl
intratrach
instil
gfpsilenc
rna
found
green
fluoresc
lung
anim
h
postinstil
reduc
least
compar
vehicletr
gfp
mice
decreas
fluoresc
seen
organ
outsid
lung
use
sirna
concentr
neither
induc
substanti
activ
type
interferon
via
activ
protein
kinas
pkr
pathway
via
classic
proinflammatori
process
line
report
demonstr
intraven
deliveri
nake
sirna
induc
interferon
respons
howev
induct
stat
signal
transduc
activ
transcript
context
appear
dose
depend
thu
rule
differ
dosag
deliveri
time
administr
might
provid
dissimilar
result
gain
insight
cellular
local
sirna
lung
follow
intrapulmonari
deposit
fluorochrom
label
sirna
uptak
confoc
immunofluores
microscopi
interestingli
label
sirna
found
coloc
lung
epitheli
cell
counterstain
h
post
instil
alveolar
macrophag
howev
neg
result
alveolar
macrophag
may
preclud
uptak
sirna
cell
type
one
imagin
differ
kinet
variou
cell
type
respect
sirna
uptak
process
rel
feasibl
gene
silenc
macrophag
use
sirna
describ
vitro
howev
silenc
typic
macrophagederiv
molecul
indirect
murin
lung
injuri
remain
unsuccess
hand
unpublish
observ
whether
might
attribut
underli
cell
type
perhap
degre
upregul
certain
gene
patholog
condit
remain
elucid
irrespect
experi
repres
first
studi
demonstr
feasibl
vivo
lung
sirna
treatment
develop
ali
final
assess
therapeut
capac
sirna
approach
experi
design
modul
pmn
immigr
base
neutrophil
hypothesi
use
vivo
sirna
construct
murin
chemokin
kc
develop
indirect
septic
ali
end
suitabl
sirna
construct
instil
lung
anim
h
follow
hem
prior
clp
ali
assess
h
induct
sepsi
silenc
markedli
reduc
tissu
plasma
concentr
tissu
well
lung
pmn
influx
interstiti
edema
alveolar
congest
disrupt
lung
tissu
architectur
contrast
kcsirna
treatment
reduc
plasma
kc
tissu
kc
tissu
produc
neither
signific
reduct
plasma
lung
pmn
influx
lung
damag
altern
base
epitheli
cell
hypothesi
sirna
sequenc
fa
intratrach
instil
septic
ali
interestingli
sequenc
markedli
diminish
lung
fa
express
gene
specif
fashion
lung
apoptosi
assess
pulmonari
tissu
activ
reduc
respons
fa
silenc
silenc
commonli
observ
result
total
deplet
target
protein
rather
diminish
express
possibl
suffici
activ
still
present
mediat
apoptot
effect
either
direct
activ
indirectli
cleavag
proapoptot
protein
bid
data
also
indic
silenc
fa
lung
epitheli
cell
associ
reduct
lung
inflamm
pmn
influx
diminish
extent
lung
injuri
thu
emphas
relev
epitheli
cell
integr
indirect
septic
ali
keep
mind
divers
clinic
scenario
use
inclus
acronym
ali
one
could
think
might
exactli
imprecis
global
view
prohibit
develop
novel
therapeut
approach
ard
divers
underli
patholog
mechan
prohibit
formul
unifi
pathophysiolog
clinic
entiti
whether
differ
form
ali
exampl
direct
versu
indirect
respons
certain
pathomechan
anoth
remain
determin
howev
may
numer
divers
stimuli
initi
pathogenesi
clinic
entiti
final
step
aliard
compromis
alveolocapillari
barrier
function
appear
somewhat
common
review
data
support
role
activ
pmn
lung
injuri
well
contribut
epitheli
cell
death
independ
entiti
contribut
ali
shown
recent
studi
look
epitheli
cell
silenc
fasinduc
apoptosi
andor
inflamm
cell
may
serv
lynchpin
link
two
patholog
process
upon
earli
fa
activ
alveolar
macrophag
lung
epitheli
cell
might
produc
chemokin
lung
thu
attract
activ
potenti
harm
neutrophil
monocyt
even
tlymphocyt
site
injuri
potenti
degre
injuri
final
trust
illustr
applic
sirnainduc
gene
knockdown
lung
produc
novel
insight
pathogenesi
ali
may
repres
potenti
excit
therapeut
approach
treatment
